News Pfizer bulks up in RSV with $525m takeover of ReViral Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in
News Clinical trial go-between Inato raises $20m Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?